Quick Answer
Climb Bio, Inc. reported Total Assets of $167.74 million for fiscal year 2025.
Climb Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $167.74M | -22.8% |
| 2024 | $217.19M | +96.6% |
| 2023 | $110.47M | -18.2% |
| 2022 | $134.99M | -22.1% |
| 2021 | $173.24M | +603.3% |
| 2020 | $24.63M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $182.30M | -18.0% | -5.2% |
| June 30, 2025 | $192.39M | -14.9% | -4.2% |
| March 31, 2025 | $200.74M | +83.6% | -7.6% |
| December 31, 2024 | $217.19M | +96.6% | -2.3% |
| September 30, 2024 | $222.20M | +97.1% | -1.7% |
| June 30, 2024 | $226.02M | +94.4% | +106.7% |
| March 31, 2024 | $109.33M | -10.4% | -1.0% |
| December 31, 2023 | $110.47M | -18.2% | -2.0% |
- Climb Bio, Inc. showed a decrease of -22.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Climb Bio, Inc.’s total assets has grown by 581.0% (from $24.63 million to $167.74 million).
- The most recent figure is from Climb Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: